Karen Prange
CIK 1566083 · EVP&CEO Gl.AH.Med.Den.Sur.Grp · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.20M
Companies
8
Total Filings
54
Lifetime Open-Market Net
-$1.24M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OM | Director | 29,334 | $4.49 | $131.7K | $0 | 2 | 2026-06-05 |
| ATRC | Director | 26,373 | $28.79 | $759.3K | -$352.6K | 11 | 2026-05-22 |
| EMBC | Director | 64,581 | $3.10 | $200.2K | $0 | 5 | 2026-02-13 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | $0 | 6 | 2025-04-03 |
| ViewRay, Inc. (VRAY) Delisted | Director | 46,399 | $0.03 | $1.2K | $91.2K | 5 | 2023-07-21 |
| CANTEL MEDICAL CORP (CMD) Delisted | Director | 0 | $80.37 | $0 | $0 | 2 | 2021-06-02 |
| HSIC | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 62,902 | $81.25 | $5.11M | $0 | 3 | 2018-03-06 |
| BOSTON SCIENTIFIC CORP (BSXw) Delisted | SVP&Pres, Uro & Pelvic Health | 39,395 | — | — | -$976.2K | 20 | 2016-03-08 |
Recent Filings · Page 4 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-05 | ATRC | Grant (A) | +5,902 | $0 | EDGAR |
| 2018-03-06 | HSIC | Grant (A) | +19,558 | $0 | EDGAR |
| 2017-03-08 | HSIC | Grant (A) | +8,777 | $0 | EDGAR |
| 2016-06-14 | HSIC | Grant (A) | +12,895 | $0 | EDGAR |
| 2016-03-08 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Sell (S) | −14,747 | -$254.7K | EDGAR |
| 2016-03-01 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +1,968 | -$30.2K | EDGAR |
| 2016-02-26 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +1,111 | -$17.2K | EDGAR |
| 2016-02-25 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +1,298 | -$17.3K | EDGAR |
| 2016-02-24 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Mixed | +25,118 | -$208.7K | EDGAR |
| 2016-02-09 | BOSTON SCIENTIFIC CORP (BSXw) Delisted | Sell (S) | −6,216 | -$99.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.